Skip to content

HealthCor Management, L.P.

Follow

13F filer, CIK 1343781, NEW YORK, NY

HealthCor Management, L.P. reported holdings worth $1,837,682,000 (the sum of its rows) across 68 holdings for the quarter ended 2021-12-31, in a 13F-HR filed 2022-02-14. The total stated on the cover page is $2,317,469,000. Its ten largest share positions make up 47.68% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001343781-22-000001

The cover page states a total of $2,317,469,000, 26% more than the sum of the rows, $1,837,682,000. This page uses the sum of the rows.

Period
2021-12-31
Value, sum of rows
$1.84B
Stated on the cover page
$2.32B
Holdings
68
Top 10 weight
47.68%
New
26
Sold out
31

Largest buys vs the previous quarter

SecurityShares changeApprox. value
MDTadded+918,100$95M
DHRnew+150,590$49.5M
ELVnew+101,560$47.1M
JNJadded+272,530$46.6M
XLVnew+254,230$35.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BMYreduced-1,779,610-$111M
MCKreduced-378,400-$94.1M
WELLexited-617,480-$50.9M
CORreduced-375,760-$49.9M
ZBHexited-330,590-$48.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2021

Share positions as resolved from 13F-HR 0001343781-22-000001, largest first. % of portfolio is the value over $1,809,066,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 796,110 shares; 2021Q2: 600,720 shares; 2021Q3: 612,480 shares; 2021Q4: 1,530,580 shares 1,530,580$158M8.75%+918,100Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 1,474,370 shares; 2021Q3: 3,584,160 shares; 2021Q4: 1,804,550 shares 1,804,550$113M6.22%-1,779,610Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 80,510 shares; 2021Q2: 339,300 shares; 2021Q3: 466,830 shares; 2021Q4: 453,400 shares 453,400$109M6.01%-13,430Timeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,725,650 shares; 2021Q2: 1,235,048 shares; 2021Q3: 1,278,228 shares; 2021Q4: 832,270 shares 832,270$89.7M4.96%-445,958
NVSTENVISTA HOLDINGS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,435,370 shares; 2021Q2: 1,165,860 shares; 2021Q3: 2,249,972 shares; 2021Q4: 1,642,680 shares 1,642,680$74M4.09%-607,292Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 789,658 shares; 2021Q3: 897,646 shares; 2021Q4: 752,920 shares 752,920$70.3M3.89%-144,726Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 583,290 shares; 2021Q2: 264,340 shares; 2021Q3: 896,680 shares; 2021Q4: 520,920 shares 520,920$69.2M3.83%-375,760Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 376,180 shares; 2021Q3: 1,084,240 shares; 2021Q4: 782,180 shares 782,180$63.9M3.53%-302,060Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 982,630 shares; 2021Q4: 750,270 shares 750,270$61.8M3.42%-232,360Timeline
WOOFPETCO HEALTH & WELLNESS CO IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 3,088,000 shares; 2021Q2: 4,944,450 shares; 2021Q3: 4,944,450 shares; 2021Q4: 2,729,450 shares 2,729,450$54M2.99%-2,215,000Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,174,820 shares; 2021Q2: 1,210,570 shares; 2021Q3: 1,707,681 shares; 2021Q4: 1,263,670 shares 1,263,670$53.7M2.97%-444,011Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 535,670 shares; 2021Q2: 384,920 shares; 2021Q3: not reported; 2021Q4: 150,590 shares 150,590$49.5M2.74%newTimeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 7,280 shares; 2021Q4: 279,810 shares 279,810$47.9M2.65%+272,530Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 91,760 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 101,560 shares 101,560$47.1M2.6%newTimeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 460,790 shares; 2021Q4: 349,080 shares 349,080$44.5M2.46%-111,710Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 273,190 shares; 2021Q3: 222,510 shares; 2021Q4: 158,940 shares 158,940$42.5M2.35%-63,570Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 125,000 shares; 2021Q3: 652,150 shares; 2021Q4: 430,600 shares 430,600$37.6M2.08%-221,550Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 325,577 shares; 2021Q3: 348,680 shares; 2021Q4: 285,620 shares 285,620$37M2.05%-63,060Timeline
XLVSELECT SECTOR SPDR TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 254,230 shares 254,230$35.8M1.98%newTimeline
THE COOPER COMPANIESTHE COOPER COMPANIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 113,167 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 80,130 shares 80,130$33.6M1.86%new
NEVRO CORPNEVRO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 376,330 shares; 2021Q3: 529,230 shares; 2021Q4: 409,230 shares 409,230$33.2M1.83%-120,000
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 4,886,440 shares; 2021Q2: 3,248,100 shares; 2021Q3: 3,849,470 shares; 2021Q4: 2,377,130 shares 2,377,130$32.9M1.82%-1,472,340Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 389,980 shares; 2021Q3: 445,739 shares; 2021Q4: 365,737 shares 365,737$31.1M1.72%-80,002Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 202,710 shares 202,710$28.5M1.58%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 251,390 shares; 2021Q2: 239,030 shares; 2021Q3: not reported; 2021Q4: 54,640 shares 54,640$25.3M1.4%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,371,480 shares; 2021Q2: 1,751,342 shares; 2021Q3: 1,214,670 shares; 2021Q4: 1,157,560 shares 1,157,560$25.3M1.4%-57,110Timeline
REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 81,500 shares; 2021Q4: 1,449,835 shares 1,449,835$23.7M1.31%+1,368,335
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 414,990 shares; 2021Q2: 169,710 shares; 2021Q3: 237,360 shares; 2021Q4: 84,270 shares 84,270$21.7M1.2%-153,090Timeline
LONGVIEW ACQUISITION CORP IILONGVIEW ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 2,135,900 shares; 2021Q3: 2,135,900 shares; 2021Q4: 2,135,900 shares 2,135,900$21M1.16%0
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 339,110 shares 339,110$20M1.11%newTimeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 428,380 shares 428,380$18.1M1%newTimeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 190,380 shares; 2021Q3: not reported; 2021Q4: 28,320 shares 28,320$17.9M0.99%newTimeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 729,420 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 125,150 shares 125,150$16.9M0.94%newTimeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 473,330 shares; 2021Q2: 160,760 shares; 2021Q3: 442,470 shares; 2021Q4: 64,070 shares 64,070$15.9M0.88%-378,400Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 29,000 shares 29,000$14.6M0.8%newTimeline
CANO HEALTH INCCANO HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 2,754,730 shares; 2021Q4: 1,586,720 shares 1,586,720$14.1M0.78%-1,168,010
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 227,450 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 159,320 shares 159,320$14.1M0.78%newTimeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 158,280 shares; 2021Q3: not reported; 2021Q4: 62,490 shares 62,490$14.1M0.78%newTimeline
RESEARCH ALLIANCE CORP IIRESEARCH ALLIANCE CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,000,000 shares; 2021Q2: 1,324,800 shares; 2021Q3: 1,324,800 shares; 2021Q4: 1,324,800 shares 1,324,800$12.9M0.71%0
HSICSCHEIN HENRY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 127,610 shares 127,610$9.89M0.55%newTimeline
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 200,000 shares; 2021Q4: 1,310,340 shares 1,310,340$9.72M0.54%+1,110,340
AFFIMED N VAFFIMED N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,587,944 shares; 2021Q2: 2,422,964 shares; 2021Q3: 2,555,908 shares; 2021Q4: 1,721,925 shares 1,721,925$9.51M0.53%-833,983
CHEMOCENTRYX INCCHEMOCENTRYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 240,530 shares 240,530$8.76M0.48%new
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,144,287 shares; 2021Q2: not reported; 2021Q3: 75,000 shares; 2021Q4: 108,050 shares 108,050$7.93M0.44%+33,050Timeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 200,000 shares; 2021Q3: 184,700 shares; 2021Q4: 181,400 shares 181,400$6.66M0.37%-3,300
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 134,340 shares 134,340$5.7M0.31%newTimeline
SEAGEN INCSEAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 33,890 shares 33,890$5.24M0.29%new
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 691,650 shares 691,650$5.01M0.28%newTimeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 49,640 shares; 2021Q4: 119,710 shares 119,710$4.93M0.27%+70,070Timeline
ARYA SCIENCES ACQUISITN CORPARYA SCIENCES ACQUISITN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 500,000 shares; 2021Q4: 500,000 shares 500,000$4.85M0.27%0
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 462,500 shares; 2021Q2: 749,310 shares; 2021Q3: 434,500 shares; 2021Q4: 94,120 shares 94,120$4.29M0.24%-340,380Timeline
HALOHALOZYME THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 745,605 shares; 2021Q2: 649,052 shares; 2021Q3: 493,502 shares; 2021Q4: 104,482 shares 104,482$4.2M0.23%-389,020Timeline
STXSSTEREOTAXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 656,540 shares 656,540$4.07M0.23%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 17,490 shares 17,490$4.02M0.22%newTimeline
IKENA ONCOLOGY INCIKENA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 341,212 shares; 2021Q2: 377,551 shares; 2021Q3: 339,951 shares; 2021Q4: 287,621 shares 287,621$3.61M0.2%-52,330
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 60,490 shares; 2021Q2: 96,438 shares; 2021Q3: 70,898 shares; 2021Q4: 111,760 shares 111,760$3.55M0.2%+40,862
LEAP THERAPEUTICS INCLEAP THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 1,200,000 shares; 2021Q4: 1,066,689 shares 1,066,689$3.46M0.19%-133,311
AXONICS INCAXONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 58,920 shares 58,920$3.3M0.18%new
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 244,838 shares 244,838$2.69M0.15%newTimeline
ORION ACQUISITION CORPORION ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 547,598 shares; 2021Q3: 547,385 shares; 2021Q4: 199,751 shares 199,751$1.95M0.11%-347,634
DICE THERAPEUTICS INCDICE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 42,800 shares; 2021Q4: 74,774 shares 74,774$1.89M0.1%+31,974
LONGVIEW ACQUISITION CORP IILONGVIEW ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 427,178 shares; 2021Q3: 427,178 shares; 2021Q4: 427,178 shares 427,178$363K0.02%0
EQRX INCEQRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 99,998 shares 99,998$107K0.01%new
ORION ACQUISITION CORPORION ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 137,305 shares; 2021Q3: 137,305 shares; 2021Q4: 137,305 shares 137,305$89K<0.01%0
MEDICUS SCIENCES ACQUISITIONMEDICUS SCIENCES ACQUISITIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 82,663 shares; 2021Q3: 82,663 shares; 2021Q4: 82,663 shares 82,663$60K<0.01%0
EUCRATES BIOMEDICAL ACQU COREUCRATES BIOMEDICAL ACQU CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q1: restricted; 2020Q2: restricted; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 78,059 shares 78,059$45K<0.01%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MDTMEDTRONIC PLC COMcall275,000$28.4Mnew
BBIOBRIDGEBIO PHARMA INC COMcall10,000$167Knew

Sold out in Q4 2021

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
WELLWELLTOWER INC617,480$50.9Mshares
ZBHZIMMER BIOMET HOLDINGS INC330,590$48.4Mshares
CITHE CIGNA GROUP211,780$42.4Mshares
VTRVENTAS INC725,010$40Mshares
BDXBECTON DICKINSON & CO140,540$34.5Mshares
ALGNALIGN TECHNOLOGY INC46,730$31.1Mshares
VRTXVERTEX PHARMACEUTICALS INC130,290$23.6Mshares
IDXXIDEXX LABS INC35,800$22.3Mshares
INCYINCYTE CORP267,000$18.4Mcall
ZTSZOETIS INC83,060$16.1Mshares
CVSCVS HEALTH CORP173,800$14.7Mshares
DECIPHERA PHARMACEUTICALS INDECIPHERA PHARMACEUTICALS IN386,190$13.1Mshares
MRVIMARAVAI LIFESCIENCES HLDGS I250,000$12.3Mshares
BIOHAVEN PHARMACEUTICAL HOLDBIOHAVEN PHARMACEUTICAL HOLD82,183$11.4Mshares
EHCENCOMPASS HEALTH CORP119,600$8.97Mshares
FATEFATE THERAPEUTICS INC128,450$7.61Mshares
MEDICUS SCIENCES ACQUISITIONMEDICUS SCIENCES ACQUISITION744,000$7.25Mshares
BNTXBIONTECH SE23,690$6.47Mshares
GHRSGH RESEARCH PLC164,912$3.64Mshares
ABG ACQUISITION CORP IABG ACQUISITION CORP I329,400$3.21Mshares
OMEGA ALPHA SPACOMEGA ALPHA SPAC271,032$2.64Mshares
SARISSA CAPITAL ACQUISITN COSARISSA CAPITAL ACQUISITN CO262,150$2.62Mshares
RCUSARCUS BIOSCIENCES INC70,050$2.44Mshares
EUCRATES BIOMEDICAL ACQU COREUCRATES BIOMEDICAL ACQU COR234,180$2.32Mshares
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC9,890$1.75Mshares
PRCTPROCEPT BIOROBOTICS CORP37,400$1.43Mshares
ALNYALNYLAM PHARMACEUTICALS INC7,510$1.42Mshares
JIYA ACQUISITION CORPJIYA ACQUISITION CORP140,680$1.37Mshares
AVIRATEA PHARMACEUTICALS INC36,580$1.28Mshares
ATAIBECKLEY INCATAIBECKLEY INC75,000$1.11Mshares
CM LIFE SCIENCES III INCCM LIFE SCIENCES III INC99,998$214Kshares

How Q4 2021 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001343781-22-000001 base2022-02-14acceptance time not in the bulk data set